SP

Subodhchandra Purushottamdas Adeshara

Director DIN 07242986
DIN 07242986 First appointment Jul 2015
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Subodhchandra Purushottamdas Adeshara

Data last updated:

Subodhchandra Purushottamdas Adeshara was a Director at Dialforhealth India Limited (from 2015) and Director at Alidac Pharmaceuticals Limited (from 2015).

DIN 07242986
First Appointment 27 Jul 2015
Oldest Company Age 26 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dialforhealth India Limited U85110GJ2000PLC037488
Director30 Jul 20152000₹4.07 Cr (FY 2019)Amalgamated
Alidac Pharmaceuticals Limited U24230GJ2005PLC046915
Director27 Jul 20152005₹57.16 Cr (FY 2019)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dialforhealth India Limited
Alidac Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Subodhchandra Purushottamdas Adeshara

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subodhchandra Purushottamdas Adeshara

Subodhchandra Purushottamdas Adeshara was first appointed on 27 Jul 2015 as Director at Alidac Pharmaceuticals Limited.

Subodhchandra Purushottamdas Adeshara held 2 earlier board appointments: Dialforhealth India Limited (Director, from 30 Jul 2015); Alidac Pharmaceuticals Limited (Director, from 27 Jul 2015).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available